0001290929-23-000006.txt : 20230123 0001290929-23-000006.hdr.sgml : 20230123 20230123131512 ACCESSION NUMBER: 0001290929-23-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230123 FILED AS OF DATE: 20230123 DATE AS OF CHANGE: 20230123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wolf James G. CENTRAL INDEX KEY: 0001419248 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 23543379 MAIL ADDRESS: STREET 1: 105, FLYWAY DRIVE CITY: KIAWAH ISLAND STATE: SC ZIP: 29455 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2023-01-23 0 0000316253 ENZO BIOCHEM INC ENZ 0001419248 Wolf James G. 105, FLYWAY DRIVE KIAWAH ISLAND SC 29455 0 0 1 0 Common Stock, $0.01 par value 2023-01-23 4 C 0 228700 2.5 A 4043700 D Common Stock, $0.01 par value 2023-01-23 4 C 0 34500 5 A 4078200 D Common Stock, $0.01 par value 418500 I See Footnote Short Put Option (obligation to buy) 2.5 2023-01-23 4 C 0 2287 0 D 2022-11-01 2023-01-20 Common Stock, $0.01 par value 228700 0 D Short Put Option (obligation to buy) 5 2023-01-23 4 C 0 345 0 D 2022-10-28 2023-01-20 Common Stock, $0.01 par value 34500 0 D The counterparty to certain of the Reporting Person's outstanding short put options exercised such options and the Reporting Person was obligated to purchase these shares at an exercise price of $2.50 per share. The counterparty to certain of the Reporting Person's outstanding short put options exercised such options and the Reporting Person was obligated to purchase these shares at an exercise price of $5.00 per share. These 418,500 shares owned indirectly by the Reporting Person include 116,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person, 22,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person's spouse, 110,000 shares owned directly by the Reporting Person's sibling and 170,500 shares owned directly by adult children of the Reporting Person. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any. James G. Wolf 2023-01-23